These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11564808)

  • 1. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection.
    Wipasa J; Xu H; Stowers A; Good MF
    J Immunol; 2001 Oct; 167(7):3903-9. PubMed ID: 11564808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
    J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.
    Wipasa J; Hirunpetcharat C; Mahakunkijcharoen Y; Xu H; Elliott S; Good MF
    J Immunol; 2002 Jul; 169(2):944-51. PubMed ID: 12097400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria.
    Tian JH; Good MF; Hirunpetcharat C; Kumar S; Ling IT; Jackson D; Cooper J; Lukszo J; Coligan J; Ahlers J; Saul A; Berzofsky JA; Holder AA; Miller LH; Kaslow DC
    Parasite Immunol; 1998 Jun; 20(6):263-78. PubMed ID: 9651928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the 19-kDa region of merozoite surface protein 1 and whole-parasite-specific maternal antibodies in directing neonatal pups' responses to rodent malaria infection.
    Stanisic DI; Martin LB; Good MF
    J Immunol; 2003 Nov; 171(10):5461-9. PubMed ID: 14607952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodies.
    Stanisic DI; Martin LB; Gatton ML; Good MF
    J Immunol; 2004 May; 172(9):5570-81. PubMed ID: 15100300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.
    Wipasa J; Xu H; Makobongo M; Gatton M; Stowers A; Good MF
    Infect Immun; 2002 Nov; 70(11):6013-20. PubMed ID: 12379677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
    Daly TM; Long CA
    J Immunol; 1995 Jul; 155(1):236-43. PubMed ID: 7602100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.
    Hirunpetcharat C; Stanisic D; Liu XQ; Vadolas J; Strugnell RA; Lee R; Miller LH; Kaslow DC; Good MF
    Parasite Immunol; 1998 Sep; 20(9):413-20. PubMed ID: 9767608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyspecific malaria antibodies present at the time of infection inhibit the development of immunity to malaria but antibodies specific for the malaria merozoite surface protein, MSP1, facilitate immunity.
    Zhang W; Liu XQ; Xu H; Good MF
    Parasite Immunol; 2002 May; 24(5):233-41. PubMed ID: 12060317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACI Contributes to
    Parra M; Yang J; Weitner M; Derrick S; Yang A; Schmidt T; Singh B; Moreno A; Akkoyunlu M
    Front Immunol; 2018; 9():2612. PubMed ID: 30473702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge.
    Vukovic P; Chen K; Qin Liu X; Foley M; Boyd A; Kaslow D; Good MF
    Vaccine; 2002 Jun; 20(21-22):2826-35. PubMed ID: 12034110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L; Goschnick MW; Coppel RL
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
    Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
    Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice.
    Amante FH; Good MF
    Parasite Immunol; 1997 Mar; 19(3):111-26. PubMed ID: 9106817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.
    Wykes MN; Zhou YH; Liu XQ; Good MF
    J Immunol; 2005 Aug; 175(4):2510-6. PubMed ID: 16081823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.